115 related articles for article (PubMed ID: 9680920)
1. Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: an exploratory study.
Harrison T; Bigler L; Tucci M; Pratt L; Malamud F; Thigpen JT; Streckfus C; Younger H
Spec Care Dentist; 1998; 18(3):109-12. PubMed ID: 9680920
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction.
Jensen SB; Mouridsen HT; Reibel J; Brünner N; Nauntofte B
Oral Oncol; 2008 Feb; 44(2):162-73. PubMed ID: 17588802
[TBL] [Abstract][Full Text] [Related]
3. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC
J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.
Levine MN; Bramwell VH; Pritchard KI; Norris BD; Shepherd LE; Abu-Zahra H; Findlay B; Warr D; Bowman D; Myles J; Arnold A; Vandenberg T; MacKenzie R; Robert J; Ottaway J; Burnell M; Williams CK; Tu D
J Clin Oncol; 1998 Aug; 16(8):2651-8. PubMed ID: 9704715
[TBL] [Abstract][Full Text] [Related]
5. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
6. Five-year follow-up of saliva in patients treated for lymphomas.
Meurman JH; Laine P; Keinànen S; Pyrhönen S; Teerenhovi L; Lindqvist C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):447-52. PubMed ID: 9127375
[TBL] [Abstract][Full Text] [Related]
7. Effects of 12 months of exercise training on salivary secretory IgA levels in elderly subjects.
Akimoto T; Kumai Y; Akama T; Hayashi E; Murakami H; Soma R; Kuno S; Kono I
Br J Sports Med; 2003 Feb; 37(1):76-9. PubMed ID: 12547749
[TBL] [Abstract][Full Text] [Related]
8. [Basic investigation of saliva SIgA].
Yoshida N; Kimura T; Iwamiya M; Iwamoto A; Sasada M; Ito S; Kikuchi N
Kanagawa Shigaku; 1990 Dec; 25(3):369-73. PubMed ID: 2134891
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in salivary sIgA concentrations in postmenopausal women.
Johnson RB
Spec Care Dentist; 2005; 25(3):145-9. PubMed ID: 15984177
[TBL] [Abstract][Full Text] [Related]
10. Dietary intake of Agaricus bisporus white button mushroom accelerates salivary immunoglobulin A secretion in healthy volunteers.
Jeong SC; Koyyalamudi SR; Pang G
Nutrition; 2012 May; 28(5):527-31. PubMed ID: 22113068
[TBL] [Abstract][Full Text] [Related]
11. Salivary IgA secretion rate in young and elderly persons.
Miletic ID; Schiffman SS; Miletic VD; Sattely-Miller EA
Physiol Behav; 1996 Jul; 60(1):243-8. PubMed ID: 8804670
[TBL] [Abstract][Full Text] [Related]
12. Minor salivary gland secretion rates and immunoglobulin A in adults and the elderly.
Eliasson L; Birkhed D; Osterberg T; Carlén A
Eur J Oral Sci; 2006 Dec; 114(6):494-9. PubMed ID: 17184231
[TBL] [Abstract][Full Text] [Related]
13. Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study.
Ackland SP; Anton A; Breitbach GP; Colajori E; Tursi JM; Delfino C; Efremidis A; Ezzat A; Fittipaldo A; Kolaric K; Lopez M; Viaro D;
J Clin Oncol; 2001 Feb; 19(4):943-53. PubMed ID: 11181656
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma.
Bang SM; Heo DS; Lee KH; Byun JH; Chang HM; Noh DY; Choe KJ; Bang YJ; Kim SR; Kim NK
Cancer; 2000 Dec; 89(12):2521-6. PubMed ID: 11135211
[TBL] [Abstract][Full Text] [Related]
15. [Primary chemotherapy of metastatic breast carcinoma with bendamustine hydrochloride, methotrexate and fluorouracil versus cyclophosphamide, methotrexate and fluorouracil].
Ruffert K
Zentralbl Chir; 1998; 123 Suppl 5():156-8. PubMed ID: 10063603
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Cocconi G; Di Blasio B; Boni C; Bisagni G; Ceci G; Rondini E; Bella M; Leonardi F; Savoldi L; Camisa R; Bruzzi P
Cancer; 2002 Jul; 95(2):228-35. PubMed ID: 12124820
[TBL] [Abstract][Full Text] [Related]
17. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
Crump M; Tu D; Shepherd L; Levine M; Bramwell V; Pritchard K
J Clin Oncol; 2003 Aug; 21(16):3066-71. PubMed ID: 12915595
[TBL] [Abstract][Full Text] [Related]
18. Secretory immunoglobulin A concentration in non-stimulated and stimulated saliva in relation to the status of smoking.
Nakonieczna-Rudnicka M; Bachanek T; Piekarczyk W; Kobyłecka E
Przegl Lek; 2016; 73(10):704-7. PubMed ID: 29688687
[TBL] [Abstract][Full Text] [Related]
19. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.
Fisher B; Dignam J; Mamounas EP; Costantino JP; Wickerham DL; Redmond C; Wolmark N; Dimitrov NV; Bowman DM; Glass AG; Atkins JN; Abramson N; Sutherland CM; Aron BS; Margolese RG
J Clin Oncol; 1996 Jul; 14(7):1982-92. PubMed ID: 8683228
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
Ejlertsen B; Mouridsen HT; Jensen MB
Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
